1. Home
  2. IKT vs ATLO Comparison

IKT vs ATLO Comparison

Compare IKT & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibikase Therapeutics Inc.

IKT

Inhibikase Therapeutics Inc.

HOLD

Current Price

$1.67

Market Cap

215.2M

Sector

Health Care

ML Signal

HOLD

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$30.11

Market Cap

253.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IKT
ATLO
Founded
2008
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
215.2M
253.0M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
IKT
ATLO
Price
$1.67
$30.11
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
673.0K
63.1K
Earning Date
03-26-2026
04-24-2026
Dividend Yield
N/A
3.43%
EPS Growth
57.76
8.03
EPS
N/A
0.38
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$79.37
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$16.94
52 Week High
$2.26
$30.92

Technical Indicators

Market Signals
Indicator
IKT
ATLO
Relative Strength Index (RSI) 44.94 68.56
Support Level $1.64 $27.55
Resistance Level $1.76 N/A
Average True Range (ATR) 0.07 0.56
MACD -0.00 0.16
Stochastic Oscillator 40.54 71.10

Price Performance

Historical Comparison
IKT
ATLO

About IKT Inhibikase Therapeutics Inc.

Inhibikase Therapeutics Inc a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases, namely, Pulmonary Arterial Hypertension (PAH), in which aberrant signaling through type III receptor tyrosine kinases, including platelet derived growth factor receptors and a stem cell factor receptor, known as c-Kit, has been implicated. Its product candidate is IKT-001, a prodrug of imatinib mesylate (imatinib), for PAH which is an orphan indication. The company has developed its own portfolio of protein kinase inhibitors to treat bacterial and viral infections, including viral infections in the brain. It has one reporting segment, which is the business of developing protein kinase inhibitor therapeutics.

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

Share on Social Networks: